Vesanoid, the first vitamin A derivative that's been approved for treating cancer

January 1996

Roche is now marketing Vesanoid, the first vitamin A derivative that's been approved for treating cancer.

Vesanoid is an oral form of tretinoin...the same ingredient that's in Retin-A.

Retinoids don't kill cancer cells like traditional chemo-therapy. They help get immature cancer cells to differentiate, and mature normally. These mature cells then die naturally. Vesanoid is only approved for a rare form of leukemia. But oral retinoids also show promise for lung, breast, and ovarian cancers.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote